Catalent is vulnerable to facility closures whether from natural disasters or manufacturing issues, and a warning letter from the FDA or other regulatory agency can result in manufacturing delays or ...

Quanta Dialysis Technologies has raised $60 million to expand its U.S. commercial presence for its Quanta dialysis system.

Capital Group Global Growth Equity is for global diversification in growth stocks with top tech and healthcare holdings.

With the initiation of this Phase 2 CMT clinical trial, NMD Pharma now has three ongoing global clinical trials investigating NMD670 across rare neuromuscular diseases characterized by a high degree ...

We came across a bullish thesis on Avid Bioservices, Inc. (CDMO) on Twitter by northeasternsvf. In this article, we will ...

Below is our Corporate / M&A decisions update covering decisions in the second quarter of 2024. Decisions from the Delaware Court of Chancery ...

A biotech startup’s journey to unicorn status hinges on its leadership and the culture fostered within the organization. A ...

Polen Capital, an investment management company, released its “Polen Global Growth Strategy” third-quarter 2024 investor ...

Greenhaven Road Capital, an investment management company, released its third-quarter 2024 investor letter. A copy of the ...

Halozyme Therapeutics said on Thursday it has proposed to buy German drug developer Evotec for about 2 billion euros ($2.10 billion), to bulk up its drug discovery and development portfolio.

This health news summary explores various pharmaceutical developments including Novo Nordisk's phasing out of insulin pens, a ...

Plus: How AI can make it easier to find drugs from nature and a study suggests Ozempic could treat alcoholism.